May 3, 2022
Systems Biology in Reproductive MedicineIs there a role for small molecule metabolite biomarkers in the development of a diagnostic test for endometriosis?
Endometriosis currently requires surgery and biopsy to obtain a diagnosis which is highly invasive and not without risk. Dr Holdsworth-Carson recently published a review summarising progress to date with regard to a non-invasive biomarker for endometriosis. "The identification of a non-invasive endometriosis biomarker – a measurable factor correlating with disease presence or activity – has therefore become a priority in endometriosis research, although no biomarker has yet been validated. As small molecule metabolites and lipids have emerged as a potential focus, this review with systematic approach, aims to summarize studies examining metabolomic biomarkers of endometriosis in order to guide future research."
Our project 4 continues this important work and hopefully lead to better diagnostic tests for people in the future.
![](https://assets-global.website-files.com/61242fa491a2cb735c7fb1be/6270917fe7a7492aaf27692f_systems%20biology%20vol%2068.jpg)